Asensus Surgical Inc (ASXC)
0.2466
0.00 (0.00%)
USD |
NYAM |
Apr 30, 16:00
0.2474
0.00 (0.00%)
After-Hours: 20:00
Asensus Surgical Enterprise Value: 46.00M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 46.00M |
| April 29, 2024 | 46.93M |
| April 26, 2024 | 46.66M |
| April 25, 2024 | 44.48M |
| April 24, 2024 | 45.03M |
| April 23, 2024 | 46.66M |
| April 22, 2024 | 46.93M |
| April 19, 2024 | 46.93M |
| April 18, 2024 | 47.66M |
| April 17, 2024 | 49.65M |
| April 16, 2024 | 49.92M |
| April 15, 2024 | 53.73M |
| April 12, 2024 | 52.64M |
| April 11, 2024 | 54.57M |
| April 10, 2024 | 53.70M |
| April 09, 2024 | 52.04M |
| April 08, 2024 | 51.06M |
| April 05, 2024 | 51.55M |
| April 04, 2024 | 52.37M |
| April 03, 2024 | 56.45M |
| April 02, 2024 | 36.97M |
| April 01, 2024 | 38.77M |
| March 28, 2024 | 41.49M |
| March 27, 2024 | 42.58M |
| March 26, 2024 | 41.49M |
| Date | Value |
|---|---|
| March 25, 2024 | 44.48M |
| March 22, 2024 | 44.24M |
| March 21, 2024 | 55.09M |
| March 20, 2024 | 57.27M |
| March 19, 2024 | 55.09M |
| March 18, 2024 | 56.45M |
| March 15, 2024 | 55.09M |
| March 14, 2024 | 55.50M |
| March 13, 2024 | 56.03M |
| March 12, 2024 | 54.97M |
| March 11, 2024 | 57.48M |
| March 08, 2024 | 58.41M |
| March 07, 2024 | 56.58M |
| March 06, 2024 | 57.96M |
| March 05, 2024 | 57.08M |
| March 04, 2024 | 61.03M |
| March 01, 2024 | 59.73M |
| February 29, 2024 | 58.41M |
| February 28, 2024 | 61.35M |
| February 27, 2024 | 59.73M |
| February 26, 2024 | 57.56M |
| February 23, 2024 | 59.79M |
| February 22, 2024 | 54.44M |
| February 21, 2024 | 55.76M |
| February 20, 2024 | 56.10M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.67M
Minimum
Dec 28 2022
1.407B
Maximum
Feb 10 2021
140.58M
Average
54.81M
Median
Feb 08 2024
Enterprise Value Benchmarks
| Glaukos Corp | 4.805B |
| Perspective Therapeutics Inc | 978.51M |
| Retractable Technologies Inc | -13.49M |
| Xtant Medical Holdings Inc | 132.57M |
| Catheter Precision Inc | 0.776M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.24M |
| Revenue (Quarterly) | 5.431M |
| Total Expenses (Quarterly) | 20.76M |
| EPS Diluted (Quarterly) | -0.06 |
| Gross Profit Margin (Quarterly) | 21.47% |
| Profit Margin (Quarterly) | -317.3% |
| Earnings Yield | -125.7% |
| Normalized Earnings Yield | -125.54 |